Methods and compositions for treating and preventing respiratory related diseases and conditions with xylitol-headgroup lipid analogs
US11278556B2 · kind B2 · utility
0Cited by
0References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 27, 2018 |
| Grant date | Mar 22, 2022 |
| Priority date | — |
| Expiry date | Feb 27, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention generally relates to methods to prevent and/or inhibit viral infection as well as to inhibit inflammation and/or pathogen infection by administering at least one xylitol lipid analog or compositions comprising at least one xylitol lipid analog to an individual. The invention also relates to methods to prevent or inhibit respiratory syncytial virus (RSV) infection by administering at least one xylitol lipid analog or compositions comprising at least one xylitol lipid analog to an individual.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.